Fast, Simple, and Accurate PCR Testing for Urgent Care

Cepheid, a leader in molecular diagnostics, offers solutions that increase urgent care efficiency while achieving better clinical care.

GeneXpert® Family of Systems Deliver Unmatched Results from Decentralized Testing to the Point of Care

Urgent Care Clinics play a critical role in the healthcare ecosystem by providing frontline emergency care at a fraction of the cost of traditional Emergency Departments. From patients presenting respiratory distress with overlapping ILI symptoms to rapid diagnosis of sexual health diseases, this range of care needs brings unique challenges to standalone advance care clinics. Cepheid offers proven purpose-built solutions that increase your clinic efficiency while achieving higher patient satisfaction and better clinical care.

Explore the GeneXpert® system and the GeneXpert® Xpress system, as well as our extensive respiratory and sexual health test menu, to take your Urgent Care Clinic to the next level.

GX Systems Test Menu

Seamless In-office Testing

  • Reduced footprint with barcode scanners and touchscreen available on GeneXpert® Xpress
  • Simple workflow with minimal hands-on time and walk away capabilities for unparalleled efficiency
  • No specialized training and reduced daily maintenance required
  • Compact and scalable design options to grow with your testing needs
  • On-demand and random access with mix-and-match test capabilities for optimal flexibility
  • Closed cartridge technology reduces the risk of contamination and enables random-access

Testing as simple as 1, 2, 3

Respiratory Solutions

Build your Urgent Care with a Single Solution
 for Respiratory Care

Test with the confidence of PCR using Cepheid’s GeneXpert® System and Xpress® tests. Standardized CLIA waived molecular testing for any urgent care setting — from health systems to standalone practices. Achieve accurate, actionable results when and where they are needed the most.

Xpert® Xpress CoV-2/Flu/RSV plus

Xpert® Xpress CoV-2/Flu/RSV plus

Actionable rapid respiratory results to meet the challenges of co-circulating respiratory viruses
Xpert® Xpress CoV-2 plus

Xpert® Xpress CoV-2 plus

Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2
Xpert® Xpress Flu

Xpert® Xpress Flu

A multi-target approach for the detection of influenza to mitigate potential impact of genetic shift and drift on strain detection
Xpert® Xpress Strep A

Xpert® Xpress Strep A

Delivers accurate and timely results that optimizes fast treatment decisions

Accuracy, your diagnosis requires it and your patients rely on it. Day in and day out, the accuracy of test results is critical to the patient experience at your urgent care. The rapid evolution of COVID-19 is contributing to more transmission and infection than ever before. As these pathogens evolve and spread through our community, more patients will arrive at your front door. How are you going to diagnose them all? PCR testing, PCR is one of the most powerful tools for detecting COVID and other respiratory diseases. One of the reasons PCR is so effective is that it can accurately detect multiple gene targets, which is important for more confident results as the virus continues to mutate. We know that viral concentrations can vary significantly from patient to patient, and as a result, a highly sensitive test is vital to detecting both high and low viral loads. Now that SARS-CoV-2 has joined influenza and RSV viruses in common circulation, everyone is at heightened risk.

Because these respiratory illnesses all share similar symptoms, their diagnosis can be complicated, so the detection and differentiation of multiple respiratory viruses is an essential tool for your practice. That's why the CDC is encouraging labs to consider adopting a multiplex method this year. Where do you get fast, accurate results while maintaining a simple workflow? With Cepheid's GeneXpert Xpress system and the Xpert Xpress CoV-2/Flu/RSV plus test. Once offered exclusively through professional laboratories, the GeneXpert Xpress system brings the power of PCR to an urgent care setting. At Cepheid, we pride ourselves on manufacturing the world's most innovative molecular diagnostic tests and systems. That's how we help urgent care clinics adapt to today's changing world. Give yourself the advantage you need this respiratory season. With the gold standard of PCR testing, your patients will get the speed and accuracy they deserve, and you get the information you need to offer critical diagnosis at the right time. Differentiate your urgent care. Learn how at cepheid.com.

Women’s and Sexual Health Solutions

Build Your Urgent Care Clinic with a Single Solution for Women's and Sexual Health Testing

Urgent Care is at the forefront of the fight against STIs. With same-day results, your practice can promote proper antibiotic stewardship and help with treatment compliance.Achieve accurate, actionable results when and where they are needed the most.

Xpert® TV

Xpert® TV

Fast and Accurate Diagnosis of Trichomoniasis in 90 minutes or less
Xpert® CT/NG

Xpert® CT/NG

90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
Xpert® Xpress MVP

Xpert® Xpress MVP

Multiplex vaginal panel that enables results within 60 minutes from a single specimen for Bacterial Vaginosis, Vulvovaginal Candidiasis, and Trichomoniasis

- For use in a CLIA-certified facility 

Whitney Engeran-Cordova:

Los Angeles is indicative of many other metropolitan areas in the United States seeing large increases in STI rates, and the number of cases have increased 36% over the last five years. AHF was really founded on the premise of taking care of people when they really needed it the most. We started here in Los Angeles, taking care of people who didn't have any place else to go. And over the years, we have expanded that mission into healthcare, and at this point, we have 455 healthcare centers serving over 800,000 people in 38 countries. And so we've found, along the way, that we've really had to address sexual health needs of our communities, and that has turned into a Wellness Center network around the country, where we work towards doing STD screening and treatment, along with our HIV services.

Patient 1:

When I came here and I was at a low point in my life, they was actually there to let me know, "We're here, we're here to help you, and you'll get your results back soon, and we'll take care of you." And it made me feel more like family.

Patient 2:

What I like about the Broward Wellness Center is the safe place feel to it. I can come here and I know that I'm not going to be judged. The staff is very, very kind and loving to everyone that comes in here.

Adam Sukhija-Cohen:

To truly have an impact on our patients, we have to ensure that not only are they being tested and treated, but that their partners are not getting infected. So we really want to nip this in the bud, and get that primary patient into our care by treating them for the infection that they may have, so that that doesn't spread to further populations.

Whitney Engeran-Cordova:

We want to be in the middle of that conversation, because we feel we've found a formula in our Wellness Centers that really works for many different folks.

Robert Parisi:

AHF has a huge presence in South Florida, and we have mobile units, we have fixed sites, we have healthcare centers, and we do the Florida AIDS Walk. Broward Wellness started in 2013, and we started out with about 75 patients, and now we're averaging between 140 and 150 patients per day.

Adam Sukhija-Cohen:

With this rising STD epidemic, that has no sign of slowing down at this point, we need to look for new, innovative technological point-of-care services that can really have an impact in the longterm. And that means that we want to make sure that they get those results as soon as possible.

Whitney Engeran-Cordova:

It's been clear to us that we had to figure out how to go fast, and one of the biggest places we need to go fast is in figuring out how to get the diagnostic work done quickly, and then deliver it to our patients in a way they're comfortable with, which means their phones.

Ramin Bastani:

That's where we're seeing over 90% of the hundreds of thousands of patients we've worked with access their information, is on their mobile phones. And now when you throw Cepheid into the mix, you're going to get test results back coming in the same day. And that hasn't happened in the US before.

Patient 1:

Once I come in this place and I'm walking out, I have my results the same day. That's what I love the most.

Ramin Bastani:

With AHF Wellness across the country where we work with them, it's over 90% of patients are saying, "Yeah, this was a good experience." And we hear about patients driving for five hours in some cases, just to go to the Wellness Centers that they have, because they know they're going to get this kind of experience that really treats them like a patient and a human being.

Patient 2:

I come here for the free testing. They do HIV, syphilis, gonorrhea, and chlamydia. It's super fast, super easy.

Lisa Zlotziver:

It's amazing how fast we can turn around patient results now. In less than two hours, we can have results, and they're valid results because the machine checks the sample, the adequacy, and the results are good. I stand behind my results.

Margaret Daley:

This organization is really at the top of its game because of this instrument. They're able to provide so much more than even a hospital lab could provide.

Robert Parisi:

AHF always goes above and beyond, and the collaboration with Cepheid will certainly bring us over the top. We'll definitely see more clients. And once again, it's about servicing the patients and reducing that anxiety, reducing the stigma, and making STIs just part of routine health testing.

Educational Materials

Select your area of interest

US-IVD. In Vitro Diagnostic Medical Device

Please see individual product inserts for full test run times and early assay termination times.

Please see Product inserts for individual test clearances.

*These tests have not been FDA cleared or approved. These tests have been authorized for emergency use by FDA under an EUA for use by authorized laboratories. Xpert Xpress CoV-2 plus has been authorized only for the detection of nucleic acids from SARS-CoV-2, and not for any other viruses or pathogens. Xpert Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

1Gaydos C, et al. Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management:
Report of a Randomized Clinical Trial. Ann Emerg Med. Sept 2018.